Condition: HIV Infections · Sexually Transmitted Diseases · Sponsor: Public Health Foundation Enterprises, Inc.
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Bridge HIV, San Francisco Department of Public Health | San Francisco, California, United States | Active Not Recruiting |
| San Francisco AIDS Foundation | San Francisco, California, United States | Recruiting |
| Whitman-Walker Health | Washington D.C., District of Columbia, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04855773